Clinical Trials Browser

Has results × Urothelial Cancer × pembrolizumab × Clear all

NCT03390504 2026-04-13

THOR

Phase 3 Active not recruiting

629 enrolled 32 charts

Urothelial Cancer

NCT04223856 2025-06-13

EV-302

Phase 3 Active not recruiting

886 enrolled 12 charts 2 FDA

Urothelial Cancer